Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6984 | 1419 | 32.8 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
99 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 74452 |
107 | 2 | HEPATITIS B VIRUS//HEPATITIS B//CHRONIC HEPATITIS B | 25371 |
6984 | 1 | BIO NANOCAPSULE//PRES1//RECOMBINANT HEPATITIS B SURFACE ANTIGEN | 1419 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BIO NANOCAPSULE | authKW | 484849 | 2% | 87% | 26 |
2 | PRES1 | authKW | 392295 | 2% | 65% | 28 |
3 | RECOMBINANT HEPATITIS B SURFACE ANTIGEN | authKW | 131791 | 0% | 88% | 7 |
4 | ANTI PRE S2 ANTIBODY | authKW | 129104 | 0% | 100% | 6 |
5 | MYRCLUDEX B | authKW | 105925 | 1% | 62% | 8 |
6 | SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE | authKW | 98358 | 1% | 57% | 8 |
7 | HEPATITIS B SURFACE ANTIGEN | authKW | 93665 | 3% | 9% | 47 |
8 | HEPATITIS B VIRUS | authKW | 90504 | 11% | 3% | 155 |
9 | ANTIBODY ENGN UNIT | address | 76497 | 1% | 44% | 8 |
10 | PRE S2 ANTIGEN | authKW | 67238 | 0% | 63% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 25142 | 32% | 0% | 455 |
2 | Gastroenterology & Hepatology | 2746 | 14% | 0% | 197 |
3 | Immunology | 1143 | 15% | 0% | 214 |
4 | Biotechnology & Applied Microbiology | 962 | 12% | 0% | 174 |
5 | Biochemical Research Methods | 544 | 7% | 0% | 105 |
6 | Medicine, Research & Experimental | 292 | 6% | 0% | 92 |
7 | Biochemistry & Molecular Biology | 279 | 16% | 0% | 226 |
8 | Biology | 204 | 4% | 0% | 58 |
9 | Infectious Diseases | 85 | 3% | 0% | 44 |
10 | Cell Biology | 50 | 5% | 0% | 74 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIBODY ENGN UNIT | 76497 | 1% | 44% | 8 |
2 | OTTO MEYERHOF ZENTRUM | 43558 | 1% | 23% | 9 |
3 | DIRECT QUAL CONTROL | 43035 | 0% | 100% | 2 |
4 | MED VIROLBIOMED SELTERSBERG | 43035 | 0% | 100% | 2 |
5 | REAGENTS DIAGNOST | 43035 | 0% | 100% | 2 |
6 | ROGEN INC | 43035 | 0% | 100% | 2 |
7 | VIRAL GLYCOPROT | 33614 | 0% | 31% | 5 |
8 | MEDEVA DEV | 28688 | 0% | 67% | 2 |
9 | OKAYAMA PK INCUBAT | 28688 | 0% | 67% | 2 |
10 | OMZ | 28688 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION | 10744 | 1% | 3% | 17 |
2 | JOURNAL OF VIROLOGY | 7961 | 9% | 0% | 122 |
3 | JOURNAL OF MEDICAL VIROLOGY | 7291 | 4% | 1% | 51 |
4 | HEPATOLOGY | 4653 | 4% | 0% | 51 |
5 | VIROLOGY | 3687 | 4% | 0% | 57 |
6 | INTERVIROLOGY | 3279 | 1% | 1% | 17 |
7 | JOURNAL OF GENERAL VIROLOGY | 3055 | 3% | 0% | 44 |
8 | JOURNAL OF VIRAL HEPATITIS | 2787 | 1% | 1% | 17 |
9 | VACCINE | 2038 | 3% | 0% | 42 |
10 | JOURNAL OF VIROLOGICAL METHODS | 1886 | 2% | 0% | 25 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BIO NANOCAPSULE | 484849 | 2% | 87% | 26 | Search BIO+NANOCAPSULE | Search BIO+NANOCAPSULE |
2 | PRES1 | 392295 | 2% | 65% | 28 | Search PRES1 | Search PRES1 |
3 | RECOMBINANT HEPATITIS B SURFACE ANTIGEN | 131791 | 0% | 88% | 7 | Search RECOMBINANT+HEPATITIS+B+SURFACE+ANTIGEN | Search RECOMBINANT+HEPATITIS+B+SURFACE+ANTIGEN |
4 | ANTI PRE S2 ANTIBODY | 129104 | 0% | 100% | 6 | Search ANTI+PRE+S2+ANTIBODY | Search ANTI+PRE+S2+ANTIBODY |
5 | MYRCLUDEX B | 105925 | 1% | 62% | 8 | Search MYRCLUDEX+B | Search MYRCLUDEX+B |
6 | SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE | 98358 | 1% | 57% | 8 | Search SODIUM+TAUROCHOLATE+COTRANSPORTING+POLYPEPTIDE | Search SODIUM+TAUROCHOLATE+COTRANSPORTING+POLYPEPTIDE |
7 | HEPATITIS B SURFACE ANTIGEN | 93665 | 3% | 9% | 47 | Search HEPATITIS+B+SURFACE+ANTIGEN | Search HEPATITIS+B+SURFACE+ANTIGEN |
8 | HEPATITIS B VIRUS | 90504 | 11% | 3% | 155 | Search HEPATITIS+B+VIRUS | Search HEPATITIS+B+VIRUS |
9 | PRE S2 ANTIGEN | 67238 | 0% | 63% | 5 | Search PRE+S2+ANTIGEN | Search PRE+S2+ANTIGEN |
10 | HBV RECEPTOR | 64552 | 0% | 100% | 3 | Search HBV+RECEPTOR | Search HBV+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEPERE-DOUARD, C , GRIPON, P , (2010) ENTRY OF THE HEPATITIS B VIRUS.VIROLOGIE. VOL. 14. ISSUE 4. P. 269-284 | 96 | 71% | 0 |
2 | GLEBE, D , URBAN, S , (2007) VIRAL AND CELLULAR DETERMINANTS INVOLVED IN HEPADNAVIRAL ENTRY.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 13. ISSUE 1. P. 22-38 | 95 | 61% | 125 |
3 | YAN, H , LIU, Y , SUI, JH , LI, WH , (2015) NTCP OPENS THE DOOR FOR HEPATITIS B VIRUS INFECTION.ANTIVIRAL RESEARCH. VOL. 121. ISSUE . P. 24 -30 | 45 | 70% | 16 |
4 | LIU, QS , SOMIYA, M , KURODA, S , (2016) ELUCIDATION OF THE EARLY INFECTION MACHINERY OF HEPATITIS B VIRUS BY USING BIO-NANOCAPSULE.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 22. ISSUE 38. P. 8489 -8496 | 42 | 86% | 0 |
5 | LI, WH , URBAN, S , (2016) ENTRY OF HEPATITIS B AND HEPATITIS D VIRUS INTO HEPATOCYTES: BASIC INSIGHTS AND CLINICAL IMPLICATIONS.JOURNAL OF HEPATOLOGY. VOL. 64. ISSUE . P. S32 -S40 | 46 | 56% | 5 |
6 | TOITA, R , KAWANO, T , KANG, JH , MURATA, M , (2015) APPLICATIONS OF HUMAN HEPATITIS B VIRUS PRES DOMAIN IN BIO- AND NANOTECHNOLOGY.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 21. ISSUE 24. P. 7400 -7411 | 60 | 55% | 1 |
7 | XIE, Y , ZHAI, J , DENG, Q , TIOLLAIS, P , WANG, Y , ZHAO, M , (2010) ENTRY OF HEPATITIS B VIRUS: MECHANISM AND NEW THERAPEUTIC TARGET.PATHOLOGIE BIOLOGIE. VOL. 58. ISSUE 4. P. 301 -307 | 51 | 70% | 11 |
8 | LEPERE-DOUARD, C , TROTARD, M , LE SEYEC, J , GRIPON, P , (2009) THE FIRST TRANSMEMBRANE DOMAIN OF THE HEPATITIS B VIRUS LARGE ENVELOPE PROTEIN IS CRUCIAL FOR INFECTIVITY.JOURNAL OF VIROLOGY. VOL. 83. ISSUE 22. P. 11819 -11829 | 43 | 83% | 21 |
9 | SOMIYA, M , LIU, QS , YOSHIMOTO, N , IIJIMA, M , TATEMATSU, K , NAKAI, T , OKAJIMA, T , KUROKI, K , UEDA, K , KURODA, S , (2016) CELLULAR UPTAKE OF HEPATITIS B VIRUS ENVELOPE L PARTICLES IS INDEPENDENT OF SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE, BUT DEPENDENT ON HEPARAN SULFATE PROTEOGLYCAN.VIROLOGY. VOL. 497. ISSUE . P. 23 -32 | 36 | 75% | 1 |
10 | GLEBE, D , BREMER, CM , (2013) THE MOLECULAR VIROLOGY OF HEPATITIS B VIRUS.SEMINARS IN LIVER DISEASE. VOL. 33. ISSUE 2. P. 103 -112 | 48 | 56% | 24 |
Classes with closest relation at Level 1 |